ERBB2 and gastric cancer: The presence of neuromodulin, a ligand for ErbB3, leads to heterodimerization of ErbB2, ErbB3, and ErbB4, thereby reducing the cytotoxicity of T-DMI in gastric cancer cell lines (79).